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This clinical trial aimed at comparing the intensity of pain and bruising by subcutaneous and 
intramuscular injections using and retractable fixed syringes and needles and syringes with 
no needles combined, at a public hospital in Sao Paulo, for six months. We evaluated the 
perception of pain in case of intramuscular (n=1000) and subcutaneous injections (n=240). 
In subcutaneous application, bruise formation was also verified. Pain and bruising scores 
were higher in the group with no needles combined (p<0.001) and (p<0.029), respectively. 
The test power in relation to the pain scale of was 0.98. The use of retractable fixed needles 
is recommended in the application of subcutaneous and intramuscular injections. Clinical 
trial registration number: NCT01271608.
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Ensaio clínico randomizado para avaliação de dor e hematoma em 
administração de medicamentos por via subcutânea e intramuscular: 
há necessidade de troca de agulhas?
Este ensaio clínico teve como objetivo comparar a intensidade da dor e hematoma 
consequentes a injeções por via subcutânea e intramuscular, utilizando seringas e 
agulhas fixas retráteis e seringas com agulhas não conjugadas, em hospital público na 
cidade de São Paulo, durante seis meses. Foi avaliada a percepção da dor na injeção 
intramuscular (n=1.000) e na subcutânea (n=240). Na aplicação por via subcutânea, 
verificou-se também a formação de hematoma. A pontuação de dor e hematoma foi 
maior no grupo com agulhas não conjugadas (p<0,001 e p<0,029, respectivamente). O 
poder do teste em relação à escala de dor foi de 0,98. Recomenda-se o uso de agulha 
fixa retrátil na aplicação de injeções intramusculares e subcutâneas. Registro de ensaio 
clínico nº NCT01271608.
Descritores: Dor; Hematoma; Acidentes Perfurocortantes; Injeções Intramusculares; 
Injeções Subcutâneas; Injeções Intradérmicas; Prevenção de Acidentes; Dispositivos 
de Segurança.
Ensayo clínico aleatorio para evaluación del dolor y hematoma durante 
la administración de medicamentos por vía subcutánea e intramuscular: 
¿Es necesario cambiar las agujas?
Este ensayo clínico tuvo como objetivo comparar la intensidad del dolor y hematoma 
de inyecciones por vía subcutánea e intramuscular utilizando jeringas y agujas fijas 
retráctiles y jeringas con agujas no conjugadas, en un hospital público en la ciudad de 
Sao Paulo, durante seis meses. Fue evaluada la percepción del dolor de la inyección 
intramuscular (n=1000) y la subcutánea (n=240). En la aplicación por vía subcutánea 
se verificó también la formación de hematoma. La puntuación del dolor y hematoma fue 
mayor en el Grupo con agujas no conjugadas (p<0,001) y (p<0,029), respectivamente. 
El poder de la prueba en relación a la escala de dolor fue de 0,98. Se recomienda el uso 
de aguja fija retráctil en la aplicación de inyecciones intramusculares y subcutáneas. 
Registro de ensayo clínico nº NCT01271608.
Descriptores: Dolor; Hematoma; Accidentes Perforo-Cortantes; Inyecciones 
Intramusculares; Inyecciones Subcutáneas; Inyecciones Intradérmicas; Prevención de 
Accidentes; Dispositivos de Seguridad.
Introduction
The World Health Organization (WHO) recommends 
the use of safety devices for intramuscular, subcutaneous 
and intradermal medication administration. These 
devices avoid equipment reuse and health professionals’ 
contact with piercing and cutting material like needles, 
which increase the risk of biological accidents(1).
Between two and three million percutaneous 
accidents involving needles contaminated with biological 
material occur every year(2-3). A North American study 
showed that health professionals are exposed to between 
385,000 and 800,000 piercing and cutting accidents 
per year, involving risks of transmitting blood-borne 
pathogens like hepatitis B, C and HIV, among others(4). 
The impact of these accidents includes emotional damage, 
decreased productivity at work and financial impacts 
for the health system(5). Between 1995 and 2003, the 
National Surveillance System for Health Care Workers 
(NaSH) demonstrated that 26% of piercing and cutting 
accidents are associated with needle manipulation in 
patients (2,662/10,239) and 5% with needle recapping 
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(512/10,239). Six devices are responsible for 80% 
of injuries, 56% involving hollow needles and 30% 
hypodermal needles (5,612/18,708). Sixty-four percent 
of piercing and cutting accidents could be avoided. 
The Centers for Disease Control and Prevention (CDC) 
recommends that institutions establish a program to 
enhance a safety culture that includes the assessment 
of new safety devices for health professionals(6).
A systematic review on the occurrence of 
occupational infection by HIV in health workers in 
Brazil showed that the four identified cases involved 
nursing professionals and that contamination was due 
to percutaneous exposure(7).
A study on accidents involving piercing and cutting 
material among nursing workers, between 1985 and 
2000, which analyzed 39 international and 16 Brazilian 
studies, appointed that the main factors associated with 
piercing and cutting accidents were needle handling and 
recapping(8).
A study conducted at a tertiary hospital between 
July 2003 and July 2004, involving 200 cases and 200 
controls, which assessed the factors associated with 
percutaneous accidents in the nursing team, showed 
that one of the predictors was needle recapping (OR 
9.48; CI 95%)(9).
In São Paulo State, Brazil, the Biological Accident 
Notification System (SINABIO) was created as from 
1999. Out of 14,096 accidents notified until 2006 
in approximately 20% of cities in the State, it was 
evidenced that 85.5% were percutaneous, 57.7% 
involved nursing professionals and 4.2% were due to 
needle recapping(10).
In Brazil, in 2005, Ministry of Health Decree 485 was 
approved, which sets standards for occupational safety 
and health in health establishments – NR-32(11). This 
Decree established a deadline to implant safety devices 
for all piercing and cutting material(12). Implanting safety 
devices demands tests to assess their efficacy and 
adequacy to their goals. Engineering of these devices 
should permit easy handling, passive activation and 
minimal changes in the usage technique(1-2,4,6).
In Brazil, intramuscular, intradermal and 
subcutaneous drug administration is performed, 
involving the exchange of the needle through which 
the substance is aspirated to apply the drug. These 
recommendations are mentioned in different technical 
books and are based on established practices, but are 
not accompanied by scientific evidence(13-15). Most drug 
administration manuals do not address the need to 
change needles in order to apply injections(16-17).
In a literature review carried out LILACS and 
Medline, Pubmed and a dissertation and thesis bank, 
using the descriptors: “pain”, “hematoma” “exchange”, 
“intradermal injections”, “subcutaneous injections”, 
“intramuscular injections” combined with “methods”, 
“adverse events”, “prevention” and “control”, studies on 
the theme were identified.
One study recommends changing needles after 
aspiring the drug to guarantee cleanliness, needle cutting, 
adequate caliber and length, thus avoiding pain and 
contact between the drug and subcutaneous tissue(18).
Other studies also recommend changing needles 
for injection application as good practice. These 
recommendations propose that, in certain situations, 
one should clean the needles with sterile gauze or 
transfer the drug to another sterile syringe before its 
administration(19-20). Nevertheless, risks of contaminating 
the drug and equipment and accidents involving piercing 
and cutting material should be taken into account.
The Brazilian Diabetes Society recommends insulin 
preparation and application using needles combined 
with syringes. When administering two types of insulin, 
the use of needles not combined with syringes is 
recommended, so as to guarantee the aspiration of the 
correct dose(21). The CDC does not recommend changing 
needles when applying vaccines(22).
Three studies cited below assessed pain or bruising, 
comparing the drug administration technique with or 
without needle changing.
The study that compared insulin administration 
with and without needle changing demonstrated that the 
diameter of the bruise did not decrease when changing 
needles (p=0.87)(23).
The trial that involved patients (n=70) who received 
intramuscular viscous drugs through two techniques, 
with and without needle changing, demonstrated results 
without differences in pain intensity levels measured on 
the numerical scale in both groups (p<0.05)(24).
The randomized trial that compared two groups 
of pediatric patients between six months and six 
years of age who were receiving the same volume of 
a double vaccination (tetanus-diphtheria) from the 
same laboratory through the intramuscular route was 
conducted during eight weeks. The same technique was 
used for the application, with or without needle change. 
In that study, 423 patients participated and 346 forms 
were returned (81.8%). No statistically significant 
differences were found in bruising levels, hardening of 
the site or edema in the two compared groups. Likewise, 
no statistically significant difference was observed 
in systemic effects either, including fever, vomiting, 
appetite loss and crying(25).
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Needle changing for injection administration is 
a widespread practice among health professionals, 
without any scientific foundations. Today, syringes with 
retractable fixed needles are available to protect health 
professionals. In view of industrial and technological 
advances in health equipment manufacturing, research 
is needed on whether needle changing effectively 
prevents pain and bruising in case of intramuscular or 
subcutaneous injection administration.
Aims
To compare pain intensity using the numerical 
scale (0 to 10), in case of intramuscular injection and 
subcutaneous injection, applying retractable fixed needle 
syringes and the technique with needle switching;
To compare bruising after subcutaneous insulin 
administration, using retractable fixed needle syringes 
and the technique with needle switching.
Method
This randomized clinical trial was accomplished 
at two medical-surgical units – one medical-surgical 
hospitalization Unit and one Emergency Care Unit of 
a hospital in São Paulo City, between June 15th and 
November 30th 2009, after obtaining approval from the 
Institutional Review Board (CAAE - 0203.0.028.000-08).
The population comprised patients who were 
sequentially included in the study through a draft 
system, in which random figures in sealed and dark 
envelopes were used.
Sample design and size
Subcutaneous injection: the sample size was 
based on the expected proportion of bruising after the 
injection. It was expected that 40% of patients would 
present bruises as a result of the conventional technique 
and 20% when using the technique under analysis for 
subcutaneous applications. Setting a 5% alpha error 
(p=0.05) and 80% study power (20% or 0.2 beta error), 
240 patients were included, 120 in each group.
Intramuscular injection: the sample size was based 
on the proportion of patients with moderate to intense 
pain. The habitual incidence level of moderate to intense 
pain was considered at 30% in case of needle switching, 
as well as an increase of up to 40% when using the 
retractable fixed needle syringe. Five hundred patients 
were included in each group.
The sample for intramuscular injection comprised 
1,000 patients, 500 for each technique, and that for 
subcutaneous injection 240 patients, 120 for each 
technique.
Patients over 18 years old who agreed to 
participate in the study were included at one single 
time for the subcutaneous and intramuscular injections. 
The monitoring took place after reading, verifying the 
understanding and signing the Free and Informed 
Consent Term. Patients using anticoagulants or with 
coagulation disorders, lesions or cutaneous alterations 
were excluded. In the intervention group, the technique 
with retractable fixed needles was used to administer 
intramuscular and subcutaneous injections. In the control 
group, the conventional medication administration 
technique was used.
The nursing teams at both medical-surgical units 
were submitted to a seven-day training program on the 
intramuscular and subcutaneous injection application 
technique using retractable fixed needle syringes and 
the conventional technique. A nurse was exclusively 
hired for this function. An assessment form and the 
adapted numerical scale for pain assessment were used 
as data collection instruments(26). On the assessment 
form, all study variables of interest (initials, gender, age, 
baseline disease, hospitalization date, medication use, 
body mass index, bruise size, application site, drug name 
and administered volume) were registered. For those 
patients who received the subcutaneous injections, the 
bruise size in millimeters was included, when present. 
The body mass index was verified through the following 
formula: weight in kilos /(height in meters)(2).
After the patient’s consent, the assessment form 
was completed, taken from a sealed envelope, which 
the professional opened, after which (s)he applied the 
intramuscular or subcutaneous injection, using the 
conventional technique or retractable fixed syringe, 
according to the randomization. After the injection 
application, the patient was shown a numerical scale 
ranging from 0 to 10 in order to score the pain the 
injection application had caused. In the subcutaneous 
injection group, after 24 hours, the nurse measured 
bruise size with a millimeter ruler. Patients were included 
in the study until completing the necessary sample size.
Syringes and needles used
Conventional technique: for the intramuscular 
injection, a 5-milliliter syringe was used. After aspiring 
the drug with an 18G x 1.5” (40 x 1.2 mm) needle, it was 
disconnected from the syringe, after which a 22G x 1¼” 
(30 x 0.7 mm) needle was connected for the application. 
For the subcutaneous injection, a 1-milliliter syringe was 
used with 100 UI, connected with a fixed 26G x 0.5” (13 
x 0.45 mm) needle.
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Retractable needle technique: for the intramuscular 
injection, a 5-milliliter syringe was used with a retractable 
fixed 22G x 1½” (0.7 mm x 38 mm) needle. For the 
subcutaneous injection, a 1-milliliter syringe was used 
with 100 UI, connected with a retractable fixed 27G x ½” 
(0.4 x 12.7 mm) needle.
Injection application technique
Subcutaneous injection: the administered drug 
was insulin, according to the units prescribed to the 
patient. The application site was determined using an 
instrument to assess the body area turnover used for 
insulin application to patients, included in their files.
After determining the application site and 
performing skin antisepsis, the cutaneous fold was 
fixed with the non-dominant hand and the needle was 
introduced at a 90º angle. Without aspiration, the insulin 
was injected. In the conventional technique, the needle 
was rapidly withdrawn and the application site was 
slightly compressed with a swab without massaging. In 
the retractable needle technique, the same procedure 
was performed but, at the end of the application and 
full compression of the vial, the retractable device 
introduced the needle inside the body of the syringe 
before its removal from the subcutaneous tissue.
Intramuscular injection: the injected drugs were 
prescribed for the patient’s treatment. The volume 
ranged from 1 to 4 ml. Intramuscular injections applied 
in the dorsal-gluteal region were assessed, as that 
was the body region professionals who administered 
medication at the Emergency Care commonly used at 
the institution for this type of procedure.
The gluteal region was divided in four parts and the 
injection was applied in the external upper quadrant. 
After skin antisepsis, the needle was introduced at a 
90º angle. After applying the injection and removing the 
needle, the application site was slightly massaged. In 
the retractable needle technique, the same technique 
was performed but, at the end of the application and full 
compression of the vial, the retractable device introduced 
the needle inside the body of the syringe before it was 
removed from the dorsal-gluteal region.
At the medical-surgical hospitalization Unit, patients 
who received subcutaneous insulin were assessed. 
Control group patients received insulin through the 
conventional technique. The insulin application site was 
defined according to each patient’s application turnover 
and was outlined with a specific pen for skin marking 
after the application. Patients were assessed 24 hours 
later to detect the presence of bruising at the application 
site.
At the Emergency Care Unit, patients who received 
intramuscular drugs were assessed. All drugs were 
applied in the patients’ dorsal-gluteal region at a private 
room. The dorsal-gluteal region used for applying the 
intramuscular injections, as that was the body area 
standardized for this type of procedure at the institution’s 
Emergency Care Unit.
The collected data were processed and launched 
in an electronic Excel® worksheet. Student’s t-test was 
used to analyze the variables, with significance set at 
5%. Thus, it was considered that differences existed 
between groups if p <0.05.
Results
Table 1 shows the active ingredients and the volume 
of drugs used in intramuscular injections, applied with the 
conventional technique and retractable fixed needles.
Table 1 - Drugs (active ingredient) and volume applied in intramuscular injections, using the conventional and 
retractable fixed needle technique (n=1000)
Drug (active ingredient)*  Volume (ml)
Technique  
TotalConventional (n=500) Retractable fixed needle (n=500)
Diclofenac 3 172 162 334
Tiocolchicosido 2 66 51 117
Ketoprofen 2 59 82 141
Sodium dipyrone, promethazine, adiphenine 2 46 49 95
Tenoxicam 2 36 42 78
Sodium dipyrone 2 29 18 47
Dexamethasone 2 20 16 36
Thiamin 1 15 28 43
Dimenhydrinate, pyridoxine 1 12 4 16
Promethazine 2 11 8 19
Diazepam 2 10 10 20
Ceftriaxone† 4 6 8 14
(continue...)
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Table 1 - (continuation)
Drug (active ingredient)*  Volume (ml)
Technique  
TotalConventional (n=500) Retractable fixed needle (n=500)
Tramadol 1 6 9 15
Betamethasone 2 4 4 8
Haloperidol 1 4 6 10
Metoclopramide 2 2 1 3
Biperiden 1 1 0 1
Teicoplanin† 4 1 1 2
Imipenem† 3 0 1 1
General total  500 500 1000
*Database of active ingredients: http://www.anvisa.gov.br/medicamentos/referencia/lmr_a.pdf. 
†Flask-vial.
The administered drugs were prescribed for patient 
treatment at the Emergency Care Unit. Drug volume 
ranged between 1 and 4 ml, according to the drug or 
diluent used.
The comparison of volume distribution per technique, 
separately for each pain degree, showed that, for the 
total group of patients, no difference occurred in the 
mean pain score according to the different volumes used 
(p=0.364), according to Table 2. For this comparison, the 
Chi-Square test was used, with significance set at 5%. 
The results show no difference in volume distribution 
between the technique for any pain level.
Table 2 - Pain assessment according to volume and technique used (n=1000)
Numerical pain 
scale scores Volume
Technique
p-valueConventional Retractable fixed needle
n=500 % n=500 %
0 1 16 3.2 23 4.6 0.270
2 72 14.4 104 20.8
3 48 9.6 82 16.4
4 4 0.8 1 0.2
1 1 4 0.8 10 2.0 0.222
2 35 7.0 28 5.6
3 19 3.8 16 3.2
4 1 0.2
2 1 11 2.2 18 3.6 0.206
2 59 11.8 53 10.6
3 38 7.6 27 5.4
4 1 0.2 3 0.6
3 1 10 2.0 8 1.6 0.380
2 24 4.8 26 5.2
3 18 3.6 10 2.0
4 1 7 1.4 4 0.8 0.467
2 18 3.6 14 2.8
3 16 3.2 6 1.2
5 1 7 1.4 2 0.4 0.198
2 24 4.8 23 4.6
3 21 4.2 16 3.2
4 2 0.4
6 1 5 1.0 0.086
2 9 1.8 8 1.6
3 1 0.2 1 0.2
4 2 0.4
7 2 6 1.2 1 0.2 0.768
3 6 1.2 2 0.4
4 1 0.2
(continue...)
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Table 2 - (continuation)
Numerical pain 
scale scores Volume
Technique
p-valueConventional Retractable fixed needle
n=500 % n=500 %
8 1 2 0.4 0.202
2 4 0.8 2 0.4
3 1 0.2 3 0.6
4 1 0.2
9 2 3 0.6 ***
3 2 0.4
10 1 2 0.4 0.090
2 5 1.0 2 0.4
3 2 0.4
Total 500 500
Table 3 shows that no statistical difference was 
found for the analyzed variables with regard to the 
compared techniques.
Variable
Technique
p-value
Conventional Retractable fixed needle
Age 0.175
n 620 620
Mean 45.1 46.5
Median 43 45
Standard deviation 19.2 18.4
Minimum 14 14
Maximum 92 92
Weight 0.599
n 620 620
Mean 71.9 72.4
Median 70 70
Standard deviation 15.0 15.4
Minimum 44 40
Maximum 120 128
Height 0.286
n 620 620
Mean 1.8 1.7
Median 1.67 1.65
Standard deviation 3.1 0.1
Minimum 1.4 1.4
Maximum 78 1.98
BMI* 0.131
n 620 620
Mean 25.8 26.3
Median 24.8 25.8
Standard deviation 5.0 5.2
Minimum 16 16.3
Maximum 44.1 43.6
*BMI - Body Mass Index
the pain score is higher in the group in which the 
conventional technique was used (p<0.001). Test power 
when comparing both groups regarding the pain scale 
corresponded to 0.98 when comparing the entire sample 
and 0.97 when comparing the intramuscular injection 
group, with significance set at 5%.
Table 4 - Comparison of pain in case of conventional 
technique and retractable needle syringe (n= 1240)
Table 3 - Analysis of quantitative variables according 
to the conventional and retractable needle syringe 
technique (n= 1240)
Pain
Technique
p-value
Conventional Retractable fixed needle
N 620 620
<0.001
Mean 2.09 1.5
Median 2 1
Standard deviation 2.26 1.97
Minimum 0 0
Maximum 10 10
On the average, the bruising score is higher in the 
patient group in which the conventional technique was 
used (p<0.029), according to Table 5.
Table 5 - Comparison of bruising in subcutaneous 
application using conventional technique and retractable 
needle syringe (n=240)
Bruising
Technique
p-value
Conventional Retractable fixed needle
N 120 120
0.029
Mean 0.76 0.07
Median 0 0
Standard deviation 3.41 0.33
Minimum 0 0
Maximum 20 3
Table 4 shows difference between the groups 
regarding the pain scale, evidencing that, on average, 
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Discussion
Usually, the drug aspiration needle is exchanged 
for another with a view to intramuscular, subcutaneous 
or intradermal administration. The justifications given 
for this practice include: muscle tissue irritation, 
alteration in the sharpness of the needle bevel with a 
consequent increase in the patient’s painful sensation. 
Also, the risk of health professionals contaminating the 
aspiration needle while handling it is mentioned. These 
justifications are based on practices that are considered 
correct, without confirmatory scientific evidence. Factors 
like technological advances are not taken into account, 
which permit manufacturing material and equipment 
that facilitate care practices, offering safety and reducing 
occupational risks for health professionals.
One important reflection that is due is that aseptic 
handling of materials impedes drug contamination, 
independently of what technique is used. Professionals 
and institutions should join efforts for work practices to 
reflect this concern.
In clinical practice, the belief exists that drawing 
back retractable needles before removing them from the 
skin in case of subcutaneous injections could provoke 
traumas and bruising. This study, on the other hand, 
evidenced no major bruising when using retractable 
fixed needles to apply subcutaneous injections. This 
finding confirms that using the safety device to apply 
subcutaneous injections is safe to use with patients.
Initially, the researchers had planned to assess the 
intramuscular injection application using one single drug 
and volume but, after a pilot study at the Emergency 
Care Unit, it was observed that the time needed for data 
collection could turn the study unfeasible. Therefore, the 
decision was made to administer volumes between 1 and 
4 ml for application in the dorsal-gluteal region. When 
comparing pain levels according to the administered 
volume, no changes in pain perceptions were found, 
neither with the conventional nor with the retractable 
fixed needle technique.
Training health professionals for injection application 
with retractable fixed needles is necessary with a view 
to the clarification of doubts, adequate use of available 
resources and protection offered by the safety device.
Other studies should be conducted on injections 
with retractable needles to assess their introduction 
in clinical practice, their impact on the reduction of 
accidents with piercing-cutting material, costs associated 
with new technologies and the production of solid health 
residues.
Conclusions
Technological innovations are meant to improve 
care quality and facilitate the execution of procedures, 
guaranteeing and preserving patients and health 
professionals’ safety. The use of safety devices like 
syringes with retractable fixed needles is a prevention 
practice that guarantees compliance with NR-32, 
benefitting workers and health institutions.
Based on the obtained results, it can be affirmed 
that using syringes with retractable fixed needle safety 
devices neither compromise painful feelings when 
applying intramuscular and subcutaneous injections nor 
enhance the risk of bruising in case of subcutaneous 
applications. Thus, the use of these safety devices can 
be recommended in clinical practice.
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